No Data
No Data
TD Cowen Maintains Voyager Therapeutics(VYGR.US) With Buy Rating
AbbVie's Deal for Alzheimer's Antibody Raises Curtain for Roche News on Wednesday
Voyager Therapeutics: Strategic Opportunity Amid Market Overreaction
H.C. Wainwright Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $30
CCORF Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $14
Voyager Therapeutics Down Over 19%, on Pace for Largest Percent Decrease Since April 2022 -- Data Talk
climbing capybara : similar thoughts especially when yesterday i was down 15% but since company is doing great financially, decided to hold and wait.
BeeDeeVee712 OP climbing capybara : You literally described the back and forth I've been having in my head...I don't get why it hasn't moved (technically has dropped) after looking through and following up on their financials, they seem rather strong and I'm not really finding any sufficient reason to explain the lack of growth, especially over a period of months, you know?
climbing capybara : yup totally get you. feeling some opportunity loss and been thining if i should move on to a stock with more volume